These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 19582521)

  • 21. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.
    Bache M; Reddemann R; Said HM; Holzhausen HJ; Taubert H; Becker A; Kuhnt T; Hänsgen G; Dunst J; Vordermark D
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1481-7. PubMed ID: 17056190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression of osteopontin mRNA and its clinical significance in gastric cancer].
    Sun XJ; Zuo WS; Ma H; Hou WH; Cai SP; Jiang XH
    Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):292-5. PubMed ID: 15996323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osteopontin promotes the progression of gastric cancer through the NF-κB pathway regulated by the MAPK and PI3K.
    Liu J; Liu Q; Wan Y; Zhao Z; Yu H; Luo H; Tang Z
    Int J Oncol; 2014 Jul; 45(1):282-90. PubMed ID: 24756245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers.
    Cao DX; Li ZJ; Jiang XO; Lum YL; Khin E; Lee NP; Wu GH; Luk JM
    World J Gastroenterol; 2012 Aug; 18(30):3923-30. PubMed ID: 22912540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of the upregulated osteopontin mRNA expression in human colorectal cancer.
    Likui W; Hong W; Shuwen Z
    J Gastrointest Surg; 2010 Jan; 14(1):74-81. PubMed ID: 19763701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ablation of osteopontin suppresses N-methyl-N-nitrosourea and Helicobacter pylori-induced gastric cancer development in mice.
    Lee SH; Park JW; Go DM; Kim HK; Kwon HJ; Han SU; Kim DY
    Carcinogenesis; 2015 Dec; 36(12):1550-60. PubMed ID: 26438603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteopontin-positive infiltrating tumor-associated macrophages in bulky ampullary cancer predict survival.
    Hsu HP; Shan YS; Lai MD; Lin PW
    Cancer Biol Ther; 2010 Jul; 10(2):144-54. PubMed ID: 20495367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
    He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
    World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Constitutive phosphorylation of the FOXO1A transcription factor as a prognostic variable in gastric cancer.
    Kim JH; Kim MK; Lee HE; Cho SJ; Cho YJ; Lee BL; Lee HS; Nam SY; Lee JS; Kim WH
    Mod Pathol; 2007 Aug; 20(8):835-42. PubMed ID: 17491598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of survivin and caspase-3 in gastric cancer.
    Kania J; Konturek SJ; Marlicz K; Hahn EG; Konturek PC
    Dig Dis Sci; 2003 Feb; 48(2):266-71. PubMed ID: 12643601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteopontin as a potential biomarker of proliferation and invasiveness for lung cancer.
    Zhao B; Sun T; Meng F; Qu A; Li C; Shen H; Jin Y; Li W
    J Cancer Res Clin Oncol; 2011 Jul; 137(7):1061-70. PubMed ID: 21207061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zinc finger protein 139 expression in gastric cancer and its clinical significance.
    Li Y; Zhao Q; Fan LQ; Wang LL; Tan BB; Leng YL; Liu Y; Wang D
    World J Gastroenterol; 2014 Dec; 20(48):18346-53. PubMed ID: 25561801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High CD40 expression in gastric cancer associated with expanding type histology and liver metastasis.
    Lo SS; Wu CW; Chi CW; Li AF; Chen JH; Lui WY
    Hepatogastroenterology; 2005; 52(66):1902-4. PubMed ID: 16334803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between osteopontin and β-catenin immunohistochemical expression and prognostic parameters of colorectal carcinoma.
    Youssef NS; Osman WM
    Int J Clin Exp Pathol; 2015; 8(2):1503-14. PubMed ID: 25973035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancer.
    Rouanne M; Adam J; Goubar A; Robin A; Ohana C; Louvet E; Cormier J; Mercier O; Dorfmüller P; Fattal S; de Montpreville VT; Lebret T; Dartevelle P; Fadel E; Besse B; Olaussen KA; Auclair C; Soria JC
    BMC Cancer; 2016 Jul; 16():483. PubMed ID: 27422280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and prognostic significance of OPN and VEGF expression in patients with non-small-cell lung cancer.
    Lin Q; Guo L; Lin G; Chen Z; Chen T; Lin J; Zhang B; Gu X
    Cancer Epidemiol; 2015 Aug; 39(4):539-44. PubMed ID: 26123318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathological evaluation of biological behavior of submucosal invasive gastric carcinomas: relationship among lymph node metastasis, mucin phenotype and proliferative activity.
    Nakamoto J; Torisu R; Aoki R; Kimura Y; Yasuda M; Shiota K; Yamamoto Y; Ito S
    J Med Invest; 2007 Feb; 54(1-2):99-108. PubMed ID: 17380020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteopontin influences the invasiveness of pancreatic cancer cells and is increased in neoplastic and inflammatory conditions.
    Kolb A; Kleeff J; Guweidhi A; Esposito I; Giese NA; Adwan H; Giese T; Büchler MW; Berger MR; Friess H
    Cancer Biol Ther; 2005 Jul; 4(7):740-6. PubMed ID: 15970685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteopontin Promotes Colorectal Cancer Cell Invasion and the Stem Cell-Like Properties through the PI3K-AKT-GSK/3β-β/Catenin Pathway.
    Cheng Y; Wen G; Sun Y; Shen Y; Zeng Y; Du M; Zhu G; Wang G; Meng X
    Med Sci Monit; 2019 Apr; 25():3014-3025. PubMed ID: 31017126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of E-cadherin by hepatocyte growth factor induces aggressiveness of gastric carcinoma.
    Han SU; Lee HY; Lee JH; Kim WH; Nam H; Kim H; Cho YK; Kim MW; Lee KU
    Ann Surg; 2005 Nov; 242(5):676-83. PubMed ID: 16244541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.